Observe Medical ASA (OB:OBSRV) agreed to acquire Biim Ultrasound AS for NOK 185 million on January 14, 2022. As partial settlement of the purchase price for the transaction, the board of directors of Observe Medical has today, on 8 March 2022, resolved to increase the Company's share capital with NOK 2,124,697.38 by issuance of 8,171,913 new shares in the Company to the sellers of Biim Ultrasound, each with a nominal value of NOK 0.26. The consideration shares were issued at a subscription price of NOK 16.52 per consideration share upon conversion of an account receivable of NOK 135,000,002.76.

The proceeds from the Rights Issue will partly be used to finance the cash portion of the acquisition consideration of Biim Ultrasound. The deal is subject to approval from Observe Medical ASA (OB:OBSRV) board. The agreement is expected to be completed in March 2022.